Skip to main content

Table 3 Neurometabolic results for both analyzed regions (in mM)

From: Glutathione metabolism in the prefrontal brain of adults with high-functioning autism spectrum disorder: an MRS study

 

Dorsal anterior cingulate cortex

MANCOVA without covariates (Wilks’ lambda test p = 0.429)

MANCOVA with covariatesa (Wilks’ lambda test p = 0.564)

Dorsolateral prefrontal cortex

MANCOVA without covariates (Wilks’ lambda test p = 0.288)

MANCOVA with covariatesa (Wilks’ lambda test p = 0.262)

 

ASD (n = 24)

Controls (n = 18)

  

ASD (n = 24)

Controls (n = 18)

  

GSH

1.7939

1.9810

p = 0.076

p = 0.147

1.6017

1.6247

p = 0.706

p = 0.655

0.37068

0.26364

0.18921

0.19985

Cre

7.4948

7.9657

p = 0.048

p = 0.082

6.9109

6.6330

p = 0.013

p = 0.020

0.91646

0.39453

0.33509

0.35355

t-Cho

1.8900

1.9926

p = 0.213

p = 0.200

1.8507

1.8289

p = 0.757

p = 0.984

0.27320

0.24132

0.18029

0.27268

Glx

11.7396

12.5834

p = 0.142

p = 0.272

9.4585

9.2360

p = 0.396

p = 0.094

2.14178

1.21151

0.97482

0.58407

NAA

8.1840

8.8939

p = 0.168

p = 0.319

8.8931

8.7972

p = 0.661

p = 0.423

1.82291

1.29632

0.75962

0.59745

mI

5.8211

6.3095

p = 0.018

p = 0.036

5.0549

4.9064

p = 0.344

p = 0.456

0.73532

0.46517

0.50464

0.48836

  1. ASD autism spectrum disorder, MANCOVA multivariate analysis of covariance, p p value to test for differences between groups, GSH glutathione, Cre creatine, t-Cho phosphorylcholine + glycerylphosphorylcholine, Glx glutamate + glutamine, NAA N-acetylaspartate, mI, myo-inositol
  2. aAge, intelligence quotient, and nicotine consumption